Skip to main content

Peer Review reports

From: Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime

Original Submission
12 May 2020 Submitted Original manuscript
26 May 2020 Author responded Author comments - Santiago Palacios
Resubmission - Version 2
26 May 2020 Submitted Manuscript version 2
15 Jul 2020 Reviewed Reviewer Report
19 Jul 2020 Reviewed Reviewer Report
18 Aug 2020 Author responded Author comments - Santiago Palacios
Resubmission - Version 3
18 Aug 2020 Submitted Manuscript version 3
24 Aug 2020 Reviewed Reviewer Report
7 Sep 2020 Reviewed Reviewer Report - Onur Erol
10 Sep 2020 Author responded Author comments - Santiago Palacios
Resubmission - Version 4
10 Sep 2020 Submitted Manuscript version 4
13 Sep 2020 Author responded Author comments - Santiago Palacios
Resubmission - Version 5
13 Sep 2020 Submitted Manuscript version 5
Publishing
17 Sep 2020 Editorially accepted
2 Oct 2020 Article published 10.1186/s12905-020-01080-9

You can find further information about peer review here.

Back to article page